These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The value of 5-aminosalicylic acid in inflammatory bowel disease for patients intolerant or allergic to sulphasalazine. Donald IP; Wilkinson SP Postgrad Med J; 1985 Dec; 61(722):1047-8. PubMed ID: 2869480 [TBL] [Abstract][Full Text] [Related]
7. Is Asacol as effective as sulphasalazine in maintaining remission of Crohn's disease and ulcerative colitis? Nakshabendi IM; Duncan A; Russell RI Postgrad Med J; 1992 Mar; 68(797):189-91. PubMed ID: 1350343 [TBL] [Abstract][Full Text] [Related]
8. Pancreatitis induced by mesalamine. Erdkamp F; Houben M; Ackerman E; Breed W; van Spreeuwel J Neth J Med; 1992 Aug; 41(1-2):71-3. PubMed ID: 1407243 [TBL] [Abstract][Full Text] [Related]
9. Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid. Dew MJ; Hughes P; Harries AD; Williams G; Evans BK; Rhodes J Br Med J (Clin Res Ed); 1982 Oct; 285(6347):1012. PubMed ID: 6127137 [No Abstract] [Full Text] [Related]
10. [Experiences with phase III studies in the area of gastroenterology]. Kruis W Verh Dtsch Ges Inn Med; 1991; 97():503-6. PubMed ID: 1687301 [No Abstract] [Full Text] [Related]
11. Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease. Patel MM; Amin AF Pharm Dev Technol; 2013; 18(2):390-400. PubMed ID: 22304735 [TBL] [Abstract][Full Text] [Related]
12. Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis. A multicenter study. Sninsky CA; Cort DH; Shanahan F; Powers BJ; Sessions JT; Pruitt RE; Jacobs WH; Lo SK; Targan SR; Cerda JJ Ann Intern Med; 1991 Sep; 115(5):350-5. PubMed ID: 1863024 [TBL] [Abstract][Full Text] [Related]
13. Newer 5-aminosalicylic acid based drugs in chronic inflammatory bowel disease. Järnerot G Drugs; 1989 Jan; 37(1):73-86. PubMed ID: 2651087 [TBL] [Abstract][Full Text] [Related]
14. [Salicylic derivatives in the clinical treatment of inflammatory bowel disease: new perspectives]. Damião AO; Sipahi AM Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(5):271-8. PubMed ID: 2576896 [TBL] [Abstract][Full Text] [Related]
15. Oral 5-aminosalicyclic acid in children with colonic chronic inflammatory bowel disease: clinical and pharmacokinetic experience. Tolia V; Massoud N; Klotz U J Pediatr Gastroenterol Nutr; 1989 Apr; 8(3):333-8. PubMed ID: 2565380 [TBL] [Abstract][Full Text] [Related]